- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ , Pharmaceutical Technology - Pharma News and Development Insights. All rights reserved.
Featured Content
European Biotech Targeting Anti-ageing
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Latest Videos
Latest News
Biovian Invests €50 Million in Manufacturing Facility in Finland
July 28th 2023
The expansion project is aimed to be completed in December 2024 and the new facility will be fully operational by 2025.
Teva Pharmaceuticals and Alvotech Expand Existing Biosimilars Partnership
July 27th 2023
Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.
Roche and Alnylam Strike $2.8 Billion RNAi Deal
July 27th 2023
Roche will pay up to $2.8 billion for the rights to Alnylam’s RNA-based hypertension therapeutic.
Sanofi and Recludix Enter STAT6 Inhibitor Partnership Worth More Than $1.3 Billion
July 24th 2023
Sanofi and Recludix Pharma’s deal centers on developing treatments for various immunological and inflammatory diseases.
Crossbow Therapeutics Debuts with $80 Million in Series A Financing to Advance Antibody Therapeutics
July 24th 2023
Newly launched Crossbow Therapeutics will work to advance a novel class of antibody therapies for treating cancers.
Bristol Myers Squibb and Evotec Extend Neuroscience Pact
July 21st 2023
Under a global license agreement, Bristol Myers Squibb and Evotec will advance the development of neurodegeneration pipeline assets.
Sandoz Spin-off Gets Green Light from Novartis Board
July 21st 2023
The proposed spin-off of Sandoz into an independent entity has been approved by Novartis’ board of directors.
Pfizer and Flagship Pioneering Enter Innovation Partnership
July 21st 2023
The partnership will see Flagship and Pfizer work to create a new pipeline of innovative medicines.
Sanofi and Scribe Therapeutics Expands Genomics Collaboration
July 21st 2023
The expanded deal, now potentially worth more than $1.2 billion, will work to develop in vivo therapies, including sickle cell disease.
Novartis Acquires DTx Pharma in Deal Worth Up to $1 Billion
July 20th 2023
Novartis’ acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.